GlucoTrack, Inc.

GCTK Healthcare Medical Devices

EPS
+92.1%
Free cash flow
+3.42%
Total debt
+777.8%

Quarter to June 2026, against a year earlier

0.30 0.08 −21.05%
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−17.8×
Dividend yield
—
F-score
3/9
Altman Z
26019048.63
Beneish M
2.40
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
— — — —

+8 more quarters

EV/Sales
— — — —
EV/FCF
— — — —
Current Ratio
0.46 0.85 1.61 1.53
Net Debt/EBITDA
(0.25) 0.09 1.19 1.08
Debt/Equity
(1.11) (4.19) 1.21 1.18
Free Cash Flow Yield
— — — —
Free Cash Flow per Share
(21.64) (74.14) (191.11) (156.27)
Book value per Share
(10.42) (15.59) 136.62 91.70
Free Cash Flow
(3.62) (4.05) (3.96) (4.69)
EV/EBIT
— — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026